Old Web
English
Sign In
Acemap
>
authorDetail
>
Tosei Murase
Tosei Murase
Astellas Pharma
Medicine
General surgery
Erlotinib
Gefitinib
first line treatment
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, Double-Blind, Controlled Study to Evaluate Safety and Pharmacokinetics of Single Ascending Doses of ASP5354, an Investigational Imaging Product, in Healthy Adult Volunteers.
2021
Clinical pharmacology in drug development
Tosei Murase
Masaomi Takizawa
Lawrence Galitz
Stephen Flach
Valene Murray
Brandon Gufford
Akira Suwa
Show All
Source
Cite
Save
Citations (0)
P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC: Topic: Phase III
2017
Journal of Thoracic Oncology
Ronan Joseph Kelly
Leora Horn
James Chih-Hsin Yang
Dae-Ho Lee
Bhardwaj Desai
Tanya Fleege
Fei Jie
Srinivasu Poondru
Anne Keating
Debbie Whitcomb
Tosei Murase
Koichi Uegaki
Kouji Aoyama
Kazuhiko Nakagawa
Show All
Source
Cite
Save
Citations (1)
1